Catabolism of very low density lipoproteins in experimental nephrosis

The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 1984-10, Vol.74 (4), p.1375-1383
Hauptverfasser: GARBER, D. W, GOTTLIEB, B. A, MARSH, J. B, SPARKS, C. E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1383
container_issue 4
container_start_page 1375
container_title The Journal of clinical investigation
container_volume 74
creator GARBER, D. W
GOTTLIEB, B. A
MARSH, J. B
SPARKS, C. E
description The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.
doi_str_mv 10.1172/jci111548
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_425305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>6480830</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-2981c1519864e83ea229ff0f8cb9282c4aa2b99ebedc8eb3379069d32b44d31f3</originalsourceid><addsrcrecordid>eNpVkM1KAzEUhYMotVYXPoCQhRsXo_mdJgsXMlStFNzoeshkEpsyTYZkrPbtjbQUXd0L5zv3Hg4AlxjdYjwldyvtMMaciSMwxpyLQhAqjsEYIYILOaXiFJyltEIIM8bZCIxKJpCgaAxmlRpUEzqX1jBYuDFxC7vwBVvjkxvy7vrQxzAY5xN0Hprv3kS3Nn5QHfSmX8aQXDoHJ1Z1yVzs5wS8P87equdi8fo0rx4WhWYlGwoiBdaYYylKZgQ1ihBpLbJCN5IIoplSpJHSNKbVwjSUTiUqZUtJw1hLsaUTcL-723826wzlGFF1dZ8Tqbitg3L1f8W7Zf0RNjUjnCKe_Tc7v86xUzT2YMWo_m2yfqnmuyYze_X314HcV5f1672ukladjcprlw6YkBQxKekP9vl9PQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Catabolism of very low density lipoproteins in experimental nephrosis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>GARBER, D. W ; GOTTLIEB, B. A ; MARSH, J. B ; SPARKS, C. E</creator><creatorcontrib>GARBER, D. W ; GOTTLIEB, B. A ; MARSH, J. B ; SPARKS, C. E</creatorcontrib><description>The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/jci111548</identifier><identifier>PMID: 6480830</identifier><identifier>CODEN: JCINAO</identifier><language>eng</language><publisher>Ann Arbor, MI: American Society for Clinical Investigation</publisher><subject>Animals ; Apolipoproteins - blood ; Biological and medical sciences ; Glomerulonephritis ; Heparin - pharmacology ; Lipase - metabolism ; Lipolysis ; Lipoprotein Lipase - blood ; Lipoproteins, VLDL - blood ; Liver - enzymology ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Nephrosis - blood ; Nephrosis - chemically induced ; Puromycin Aminonucleoside ; Rats ; Rats, Inbred F344</subject><ispartof>The Journal of clinical investigation, 1984-10, Vol.74 (4), p.1375-1383</ispartof><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-2981c1519864e83ea229ff0f8cb9282c4aa2b99ebedc8eb3379069d32b44d31f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC425305/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC425305/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8930499$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6480830$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GARBER, D. W</creatorcontrib><creatorcontrib>GOTTLIEB, B. A</creatorcontrib><creatorcontrib>MARSH, J. B</creatorcontrib><creatorcontrib>SPARKS, C. E</creatorcontrib><title>Catabolism of very low density lipoproteins in experimental nephrosis</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.</description><subject>Animals</subject><subject>Apolipoproteins - blood</subject><subject>Biological and medical sciences</subject><subject>Glomerulonephritis</subject><subject>Heparin - pharmacology</subject><subject>Lipase - metabolism</subject><subject>Lipolysis</subject><subject>Lipoprotein Lipase - blood</subject><subject>Lipoproteins, VLDL - blood</subject><subject>Liver - enzymology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Nephrosis - blood</subject><subject>Nephrosis - chemically induced</subject><subject>Puromycin Aminonucleoside</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1KAzEUhYMotVYXPoCQhRsXo_mdJgsXMlStFNzoeshkEpsyTYZkrPbtjbQUXd0L5zv3Hg4AlxjdYjwldyvtMMaciSMwxpyLQhAqjsEYIYILOaXiFJyltEIIM8bZCIxKJpCgaAxmlRpUEzqX1jBYuDFxC7vwBVvjkxvy7vrQxzAY5xN0Hprv3kS3Nn5QHfSmX8aQXDoHJ1Z1yVzs5wS8P87equdi8fo0rx4WhWYlGwoiBdaYYylKZgQ1ihBpLbJCN5IIoplSpJHSNKbVwjSUTiUqZUtJw1hLsaUTcL-723826wzlGFF1dZ8Tqbitg3L1f8W7Zf0RNjUjnCKe_Tc7v86xUzT2YMWo_m2yfqnmuyYze_X314HcV5f1672ukladjcprlw6YkBQxKekP9vl9PQ</recordid><startdate>19841001</startdate><enddate>19841001</enddate><creator>GARBER, D. W</creator><creator>GOTTLIEB, B. A</creator><creator>MARSH, J. B</creator><creator>SPARKS, C. E</creator><general>American Society for Clinical Investigation</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>19841001</creationdate><title>Catabolism of very low density lipoproteins in experimental nephrosis</title><author>GARBER, D. W ; GOTTLIEB, B. A ; MARSH, J. B ; SPARKS, C. E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-2981c1519864e83ea229ff0f8cb9282c4aa2b99ebedc8eb3379069d32b44d31f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Animals</topic><topic>Apolipoproteins - blood</topic><topic>Biological and medical sciences</topic><topic>Glomerulonephritis</topic><topic>Heparin - pharmacology</topic><topic>Lipase - metabolism</topic><topic>Lipolysis</topic><topic>Lipoprotein Lipase - blood</topic><topic>Lipoproteins, VLDL - blood</topic><topic>Liver - enzymology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Nephrosis - blood</topic><topic>Nephrosis - chemically induced</topic><topic>Puromycin Aminonucleoside</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GARBER, D. W</creatorcontrib><creatorcontrib>GOTTLIEB, B. A</creatorcontrib><creatorcontrib>MARSH, J. B</creatorcontrib><creatorcontrib>SPARKS, C. E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GARBER, D. W</au><au>GOTTLIEB, B. A</au><au>MARSH, J. B</au><au>SPARKS, C. E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catabolism of very low density lipoproteins in experimental nephrosis</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>1984-10-01</date><risdate>1984</risdate><volume>74</volume><issue>4</issue><spage>1375</spage><epage>1383</epage><pages>1375-1383</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><coden>JCINAO</coden><abstract>The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.</abstract><cop>Ann Arbor, MI</cop><pub>American Society for Clinical Investigation</pub><pmid>6480830</pmid><doi>10.1172/jci111548</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 1984-10, Vol.74 (4), p.1375-1383
issn 0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_425305
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Animals
Apolipoproteins - blood
Biological and medical sciences
Glomerulonephritis
Heparin - pharmacology
Lipase - metabolism
Lipolysis
Lipoprotein Lipase - blood
Lipoproteins, VLDL - blood
Liver - enzymology
Male
Medical sciences
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Nephrosis - blood
Nephrosis - chemically induced
Puromycin Aminonucleoside
Rats
Rats, Inbred F344
title Catabolism of very low density lipoproteins in experimental nephrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A12%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catabolism%20of%20very%20low%20density%20lipoproteins%20in%20experimental%20nephrosis&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=GARBER,%20D.%20W&rft.date=1984-10-01&rft.volume=74&rft.issue=4&rft.spage=1375&rft.epage=1383&rft.pages=1375-1383&rft.issn=0021-9738&rft.eissn=1558-8238&rft.coden=JCINAO&rft_id=info:doi/10.1172/jci111548&rft_dat=%3Cpubmed_cross%3E6480830%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6480830&rfr_iscdi=true